Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trial.
Cooke GS, Hung LM, Flower B, McCabe L, Hang VTK, Thu VT, Thuan DT, Dung NT, Phuong LT, Khoa DB, An NTC, Thach PN, Huong VTT, Bich DT, Tuyen NK, Ansari MA, Le Ngoc C, Quang VM, Phuong NTN, Thao LT, Tran NB, Kestelyn E, Kingsley C, Van Doorn R, Rahman M, Pett SL, Thwaites GE, Barnes E, Day JN, Chau NVV, Walker AS.
Cooke GS, et al. Among authors: van doorn r.
Lancet. 2025 May 17;405(10491):1769-1780. doi: 10.1016/S0140-6736(25)00097-2. Epub 2025 May 8.
Lancet. 2025.
PMID: 40347964
Free article.
Clinical Trial.